Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
RETRACTION: Effects of GLP-1 Receptor Agonists on Cognitive Function in Patients With Type 2 Diabetes: A Systematic
Retraction:
S. Wan , H. Yan , Q.-Y. Sun , J.-Q. Zhu , H.-H. Wang , K.-Y. Qu , and X. Yi , "Effects of GLP-1 Receptor Agonists on Cognitive Function in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials," Diabetes, Obesity and Metabolism (Early View): https://doi.org/10.1111/dom.70201. The above article, published online on 17 October 2025 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor-in-Chief, Richard Donnelly; and John Wiley & Sons Ltd. The retraction has been agreed due to concerns raised by third parties and upon the authors' request. It was brought to the journal's attention that the original studies forming the basis of the meta-analysis presented in the article contain inconsistencies that are prone to misinterpretation. As a result, these studies were found not to be directly comparable. Consequently, the conclusions drawn in the article were determined to be affected by these issues, and their reliability was considered compromised. To their credit, the authors have agreed with this determination and requested the retraction of the article. The authors have acted responsibly after concerns were raised and following their own internal investigations of the research.
More Related Videos
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
Related Concept Videos
Random and Systematic Errors
Diabetes Mellitus: Type 2 and Gestational
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...